Yenamandra S Prabhakar

Target based drug design - a reality in virtual sphere.

Saroj Verma, Yenamandra S Prabhakar, Y. S. Prabhakar, 2015, Current medicinal chemistry.

Graph theory concepts in the rationales of anti HIV-1 compounds.

Yenamandra S Prabhakar, Y. S. Prabhakar, Utsab Debnath, 2013, Current computer-aided drug design.

C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: synthesis, biological evaluation, and QSAR study.

Ram Sagar, Yenamandra S Prabhakar, Y. S. Prabhakar, 2007, Journal of medicinal chemistry.

QSAR study about ATP-sensitive potassium channel activation of cromakalim analogues using CP-MLR approach.

Yenamandra S Prabhakar, Y. S. Prabhakar, Prithvi Singh, 2008, European journal of medicinal chemistry.

2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors.

Yenamandra S Prabhakar, Y. S. Prabhakar, Ravindra K Rawal, 2005, Bioorganic & medicinal chemistry.

CP-MLR directed QSAR studies on the antimycobacterial activity of functionalized alkenols--topological descriptors in modeling the activity.

Ram Sagar, Yenamandra S Prabhakar, M. Gupta, 2005, Bioorganic & medicinal chemistry.

Topological and physicochemical characteristics of 1,2,3,4-Tetrahydroacridin- 9(10H)-ones and their antimalarial profiles: a composite insight to the structure-activity relation.

Saroj Verma, Yenamandra S Prabhakar, Brij K Sharma, 2013, Current computer-aided drug design.

Juglone derivatives as antitubercular agents: a rationale for the activity profile.

Yenamandra S Prabhakar, Y. S. Prabhakar, Brij K Sharma, 2009, European journal of medicinal chemistry.